Gaps in access to innovative medicines | GZERO Blue Circle

New medicines don’t always reach patients, sometimes not at all. Why?

Patrick Horber, President of Novartis International, explains why there is all too often a lag between innovation and delivery – and what could close the gap.

Listen to the new episode of The Ripple Effect podcast from GZERO & Novartis.